A case of neuroleptic malignant syndrome induced by olanzapine in postpartum period

Neuroleptic malignant syndrome (NMS) is a life-threatening medical complication that occurs as a result of dopaminergic receptor blockage in nigrostriatal pathways. This syndrome is mainly accepted to be an idiosyncratic reaction for antipsychotic medications. Incidence of NMS induced by olanzapine...

Descripción completa

Detalles Bibliográficos
Autores principales: Üstündağ, Mehmet, Orak, Murat, Güloğlu, Cahfer, Sayhan, Mustafa Burak, Taş, Mahmut
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2007
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910354/
https://www.ncbi.nlm.nih.gov/pubmed/20680143
http://dx.doi.org/10.4103/0019-5545.37671
_version_ 1782184378317668352
author Üstündağ, Mehmet
Orak, Murat
Güloğlu, Cahfer
Sayhan, Mustafa Burak
Taş, Mahmut
author_facet Üstündağ, Mehmet
Orak, Murat
Güloğlu, Cahfer
Sayhan, Mustafa Burak
Taş, Mahmut
author_sort Üstündağ, Mehmet
collection PubMed
description Neuroleptic malignant syndrome (NMS) is a life-threatening medical complication that occurs as a result of dopaminergic receptor blockage in nigrostriatal pathways. This syndrome is mainly accepted to be an idiosyncratic reaction for antipsychotic medications. Incidence of NMS induced by olanzapine - an atypical antipsychotic - is extremely rare. However, there has been contradiction on postpartum period as a risk factor for NMS. This case is of interest due to the fact that it happens on postpartum period and is induced by olanzapine. We aimed in this study to evaluate the successfully cured case of neuroleptic malignant syndrome induced by olanzapine in postpartum period with the literature view.
format Text
id pubmed-2910354
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-29103542010-08-02 A case of neuroleptic malignant syndrome induced by olanzapine in postpartum period Üstündağ, Mehmet Orak, Murat Güloğlu, Cahfer Sayhan, Mustafa Burak Taş, Mahmut Indian J Psychiatry Case Report Neuroleptic malignant syndrome (NMS) is a life-threatening medical complication that occurs as a result of dopaminergic receptor blockage in nigrostriatal pathways. This syndrome is mainly accepted to be an idiosyncratic reaction for antipsychotic medications. Incidence of NMS induced by olanzapine - an atypical antipsychotic - is extremely rare. However, there has been contradiction on postpartum period as a risk factor for NMS. This case is of interest due to the fact that it happens on postpartum period and is induced by olanzapine. We aimed in this study to evaluate the successfully cured case of neuroleptic malignant syndrome induced by olanzapine in postpartum period with the literature view. Medknow Publications 2007 /pmc/articles/PMC2910354/ /pubmed/20680143 http://dx.doi.org/10.4103/0019-5545.37671 Text en © Indian Journal of Psychiatry http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Üstündağ, Mehmet
Orak, Murat
Güloğlu, Cahfer
Sayhan, Mustafa Burak
Taş, Mahmut
A case of neuroleptic malignant syndrome induced by olanzapine in postpartum period
title A case of neuroleptic malignant syndrome induced by olanzapine in postpartum period
title_full A case of neuroleptic malignant syndrome induced by olanzapine in postpartum period
title_fullStr A case of neuroleptic malignant syndrome induced by olanzapine in postpartum period
title_full_unstemmed A case of neuroleptic malignant syndrome induced by olanzapine in postpartum period
title_short A case of neuroleptic malignant syndrome induced by olanzapine in postpartum period
title_sort case of neuroleptic malignant syndrome induced by olanzapine in postpartum period
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910354/
https://www.ncbi.nlm.nih.gov/pubmed/20680143
http://dx.doi.org/10.4103/0019-5545.37671
work_keys_str_mv AT ustundagmehmet acaseofneurolepticmalignantsyndromeinducedbyolanzapineinpostpartumperiod
AT orakmurat acaseofneurolepticmalignantsyndromeinducedbyolanzapineinpostpartumperiod
AT guloglucahfer acaseofneurolepticmalignantsyndromeinducedbyolanzapineinpostpartumperiod
AT sayhanmustafaburak acaseofneurolepticmalignantsyndromeinducedbyolanzapineinpostpartumperiod
AT tasmahmut acaseofneurolepticmalignantsyndromeinducedbyolanzapineinpostpartumperiod
AT ustundagmehmet caseofneurolepticmalignantsyndromeinducedbyolanzapineinpostpartumperiod
AT orakmurat caseofneurolepticmalignantsyndromeinducedbyolanzapineinpostpartumperiod
AT guloglucahfer caseofneurolepticmalignantsyndromeinducedbyolanzapineinpostpartumperiod
AT sayhanmustafaburak caseofneurolepticmalignantsyndromeinducedbyolanzapineinpostpartumperiod
AT tasmahmut caseofneurolepticmalignantsyndromeinducedbyolanzapineinpostpartumperiod

Ejemplares similares